Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Grady

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|January 1, 1978
Hydroxamic acid oxidation--pharmacological considerationsS H Blobstein, R W Grady, S R Meshnick, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1976
The development of new iron-chelating drugsR W Grady, J H Graziano, H A Akers, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1978
Porphyrin-induced lysis of Trypanosoma brucei: a role for zincS R Meshnick, R W Grady, S H Blobstein, et al.
The Journal of Urology|August 25, 2000
Long-term followup of the hematuria-dysuria syndromeJ Chadwick Plaire, W T Snodgrass, R W Grady, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Results from a phase I clinical trial of HBEDR W Grady, A D Salbe, M W Hilgartner, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamineS Merali, K Chin, R W Grady, et al.
American Journal of Clinical Pathology|December 1, 1989
Cytoferrin, maternofetal iron transport, and neonatal hemochromatosisA S Knisely, R W Grady, E E Kramer, et al.
Clinical and Experimental Immunology|November 1, 1985
Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cellsA N Akbar, P J Giardina, M W Hilgartner, et al.
The Journal of Urology|June 7, 2000
Vaginal calculi secondary to partial vaginal outlet obstruction in pediatric patientsJ C Plaire, W T Snodgrass, R W Grady, et al.
Archives of Biochemistry and Biophysics|August 1, 1995
NF-kappa B transcription factor activation by hydrogen peroxide can be decreased by 2,3-dihydroxybenzoic acid and its ethyl ester derivativeC Sappey, J R Boelaert, S Legrand-Poels, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|January 1, 1978
Hydroxamic acid oxidation--pharmacological considerationsS H Blobstein, R W Grady, S R Meshnick, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1976
The development of new iron-chelating drugsR W Grady, J H Graziano, H A Akers, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1978
Porphyrin-induced lysis of Trypanosoma brucei: a role for zincS R Meshnick, R W Grady, S H Blobstein, et al.
The Journal of Urology|August 25, 2000
Long-term followup of the hematuria-dysuria syndromeJ Chadwick Plaire, W T Snodgrass, R W Grady, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Results from a phase I clinical trial of HBEDR W Grady, A D Salbe, M W Hilgartner, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamineS Merali, K Chin, R W Grady, et al.
American Journal of Clinical Pathology|December 1, 1989
Cytoferrin, maternofetal iron transport, and neonatal hemochromatosisA S Knisely, R W Grady, E E Kramer, et al.
Clinical and Experimental Immunology|November 1, 1985
Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cellsA N Akbar, P J Giardina, M W Hilgartner, et al.
The Journal of Urology|June 7, 2000
Vaginal calculi secondary to partial vaginal outlet obstruction in pediatric patientsJ C Plaire, W T Snodgrass, R W Grady, et al.
Archives of Biochemistry and Biophysics|August 1, 1995
NF-kappa B transcription factor activation by hydrogen peroxide can be decreased by 2,3-dihydroxybenzoic acid and its ethyl ester derivativeC Sappey, J R Boelaert, S Legrand-Poels, et al.
Pageof 9